Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

Around a 20–30% of inflammatory bowel disease (IBD) patients are diagnosed before they are 18 years old. Anti-TNF drugs can induce and maintain remission in IBD, however, up to 30% of patients do not respond. The aim of the work was to identify markers that would predict an early response to anti-TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador-Martín, Sara, Raposo-Gutiérrez, Irene, Navas-López, Víctor Manuel, Gallego-Fernández, Carmen, Moreno-Álvarez, Ana, Solar-Boga, Alfonso, Muñoz-Codoceo, Rosana, Magallares, Lorena, Martínez-Ojinaga, Eva, Fobelo, María J., Millán-Jiménez, Antonio, Rodriguez-Martinez, Alejandro, Vayo, Concepción A., Sánchez, Cesar, Tolin, Mar, Bossacoma, Ferrán, Pujol-Muncunill, Gemma, González de Caldas, Rafael, Loverdos, Inés, Blanca-García, José A., Segarra, Oscar, Eizaguirre, Francisco J., García-Romero, Ruth, Merino-Bohórquez, Vicente, Sanjurjo-Sáez, María, López-Fernández, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247673/
https://www.ncbi.nlm.nih.gov/pubmed/32397546
http://dx.doi.org/10.3390/ijms21093364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247673/
https://www.ncbi.nlm.nih.gov/pubmed/32397546
http://dx.doi.org/10.3390/ijms21093364

Ejemplares similares